Research Partnership publishes new patient Living with Rheumatoid Arthritis (EU, Japan & Canada) 2019 reports
Living with Rheumatoid Arthritis is a report based on 416 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK), 51 patients in Japan and 107 patients in Canada. The study consists of 30-minute quantitative online and qualitative telephone interviews with patients. The qualitative interviews are enhanced with insights generated from pre-interview patient exercises – such as patient diary entries - to capture in-the-moment feelings about living with rheumatoid arthritis. These reports can be purchased as a package or individually.
New appointments in our UK, Lyon and US offices
Research Partnership is delighted to announce new appointments across our offices. Boon Yap joins the Market Access team in the UK as Associate Consultant. Boon previously worked at ICON (formerly PriceSpective), where he conducted payer research and was the internal payer expert, as well as the designated country expert of China and Taiwan.
Also in the UK, Scarlett Collins joins as Research Analyst and Ana Maria Barbas Coslado joins the Fieldwork team as Field Executive.
In our US Philadelphia office, Megan Armano joins as Senior Research Executive. Megan has strong experience in syndicated and ad hoc quantitative research.
Research Partnership is listed in the Alantra Pharma Fast 50 annual report
Research Partnership has been ranked 42nd in the top 50 fastest-growing companies in the UK, with a compound annual growth rate of 12%.
The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report. This year’s report is the third iteration of their annual ranking of pharmaceutical companies and comprises those businesses that have increased their revenues at the fastest rate over the past two financial years.
PMRC New Jersey round up 2019
Earlier this month, Director, Head of New York office, Liza Pliss and Associate Director, Emily Hoffman attended the Pharmaceutical Market Research Conference in Newark, New Jersey.
Liza Pliss and Cornelia Fuller, US Lead at Sanofi also co-presented the paper, ‘Optimizing your Digital Assets with UX Research.’ In this presentation, they discussed the topic of User Experience (sometimes referred to as UX) and Usability specifically as they relate to digital assets (such as websites, apps, and other digital tools). They covered what UX is, why it is important, and walked through a case study, focusing on a specific UX tool that was used to help design a website.
Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
In addition from Q1 2019 Therapy Watch will now be tracking prescription topical treatments in both a secondary care and primary care setting providing broad visibility of the psoriasis market landscape.